We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK
94% of Lancaster students go into work or further study within six months of graduating
Links
Text available via DOI:
Banking expectations: the promises and problems of biobanks
Research output: Contribution to journal › Journal article
Published
Associated organisations
| Journal publication date | 11/2007 |
|---|---|
| Journal | Personalized medicine |
| Journal number | 4 |
| Volume | 4 |
| Number of pages | 7 |
| Pages | 463-469 |
| Original language | English |
Abstract
In the last decade, governments, medical charities, pharmaceutical companies and disease advocacy organizations have spent considerable time and money developing biobanks to aid drug discovery and the investigation of disease. This article identifies and assesses the various expectations that have driven the investment in different types of biobanks. It suggests that they have been the focus of unrealistic promises about producing a 'biobank revolution' that will transform biomedicine and healthcare. We need more modest expectations about what can be achieved, and need to tackle certain conceptual and methodological challenges for biobanks to fulfill their potential.